CompletedNCT00468143
Immediate- or extended-release Adderall for adult ADHD
About this title
A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
Read the official source — NCT00468143Medication studyAges 18–55United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 62
- Sponsor
- NYU Langone Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00468143
- Official title
Show the full official title
A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
Get this study by email
Recruitment & locations
CompletedNew York
Questions about this study
Who is behind this study?
The study sponsor is NYU Langone Health.
Did this study involve medication?
Yes. The study involved medication, including Adderall ® Immediate Release and Adderall XR ®.
Who was this study for?
Listed age limits: 18 years to 55 years.
